1.4M XNAS Volume
XNAS 21 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Srinivas G. Rao | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2025 | 175,000 | 0 | - | - | Common Shares | |
| Srinivas G. Rao | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2025 | 175,000 | 288,360 | - | - | Common Shares | |
| Sahil Kirpekar | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2025 | 100,000 | 0 | - | - | Common Shares | |
| Sahil Kirpekar | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2025 | 100,000 | 164,199 | - | - | Common Shares | |
| Anne Nagengast Johnson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2025 | 100,000 | 0 | - | - | Restricted Stock Units | |
| Anne Nagengast Johnson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2025 | 100,000 | 173,590 | - | - | Common Shares | |
| Glenn Frank Short | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2025 | 32,500 | 55,494 | - | - | Common Shares | |
| Glenn Frank Short | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2025 | 32,500 | 0 | - | - | Restricted Stock Units | |
| Kevin James Craig | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2025 | 20,000 | 0 | - | - | Restricted Stock Units | |
| Kevin James Craig | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2025 | 20,000 | 20,000 | - | - | Common Shares | |
| Anne Nagengast Johnson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 757,915 | 757,915 | - | - | Stock Option | |
| Glenn Frank Short | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 757,915 | 757,915 | - | - | Stock Option | |
| Kevin James Craig | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 757,915 | 757,915 | - | - | Stock Option | |
| Gerd Kochendoerfer | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 1,450,000 | 1,450,000 | - | - | Stock Option | |
| Srinivas G. Rao | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Oct 2024 | 709,952 | 0 | - | - | Stock Option | |
| Srinivas G. Rao | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Oct 2024 | 840,000 | 0 | - | - | Stock Option | |
| Srinivas G. Rao | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Oct 2024 | 1,307,408 | 0 | - | - | Stock Option | |
| Srinivas G. Rao | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 709,952 | 709,952 | - | - | Stock Option | |
| Srinivas G. Rao | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 840,000 | 840,000 | - | - | Stock Option | |
| Srinivas G. Rao | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 1,307,408 | 1,307,408 | - | - | Stock Option | |
| Florian Brand | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Oct 2024 | 400,688 | 0 | - | - | Stock Option | |
| Florian Brand | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 338,112 | 338,112 | - | - | Stock Option | |
| Florian Brand | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 400,688 | 400,688 | - | - | Stock Option | |
| Florian Brand | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Oct 2024 | 338,112 | 0 | - | - | Stock Option | |
| Florian Brand | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Oct 2024 | 4,240,000 | 0 | - | - | Stock Option | |
| Florian Brand | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 4,240,000 | 4,240,000 | - | - | Stock Option | |
| Christian Angermayer | Director, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Oct 2024 | 624,000 | 0 | - | - | Stock Option | |
| Christian Angermayer | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 624,000 | 624,000 | - | - | Stock Option | |
| Anne Nagengast Johnson | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Oct 2024 | 115,152 | 0 | - | - | Stock Option | |
| Anne Nagengast Johnson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 115,152 | 115,152 | - | - | Stock Option | |
| Anne Nagengast Johnson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 326,416 | 326,416 | - | - | Stock Option | |
| Anne Nagengast Johnson | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Oct 2024 | 326,416 | 0 | - | - | Stock Option | |
| Sabrina Martucci Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 103,000 | 103,000 | - | - | Stock Option | |
| Amir Kalali | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 103,000 | 103,000 | - | - | Stock Option | |
| Laurent Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 206,000 | 206,000 | - | - | Stock Option | |
| Scott Braunstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 206,000 | 206,000 | - | - | Stock Option | |
| Andrea Heslin Smiley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 103,000 | 103,000 | - | - | Stock Option | |
| Michael Auerbach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 103,000 | 103,000 | - | - | Stock Option | |
| Christian Angermayer | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 103,000 | 103,000 | - | - | Stock Option | |
| Florian Brand | See Remarks | Sale of securities on an exchange or to another person at price $ 1.92 per share. | 16 May 2024 | 151,303 | 328,697 | - | 1.9 | 290,502 | Common Shares |
| Srinivas G. Rao | See Remarks | Sale of securities on an exchange or to another person at price $ 1.85 per share. | 02 Apr 2024 | 61,640 | 113,360 | - | 1.9 | 114,034 | Common Shares |
| Sahil Kirpekar | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 1.85 per share. | 02 Apr 2024 | 35,801 | 64,199 | - | 1.9 | 66,232 | Common Shares |
| Anne Nagengast Johnson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.85 per share. | 02 Apr 2024 | 27,410 | 73,590 | - | 1.9 | 50,709 | Common Shares |
| Florian Brand | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2024 | 350,000 | 350,000 | - | - | Restricted Stock Unit | |
| Florian Brand | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2024 | 350,000 | 480,000 | - | - | Common Shares | |
| Srinivas G. Rao | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2024 | 175,000 | 175,000 | - | - | Common Shares | |
| Srinivas G. Rao | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2024 | 175,000 | 175,000 | - | - | Restricted Stock Units | |
| Srinivas G. Rao | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 800,000 | 800,000 | - | - | Stock Option | |
| Sahil Kirpekar | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2024 | 100,000 | 100,000 | - | - | Restricted Stock Units | |
| Sahil Kirpekar | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2024 | 100,000 | 100,000 | - | - | Common Shares | |
| Sahil Kirpekar | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 550,000 | 550,000 | - | - | Stock Option | |
| Anne Nagengast Johnson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2024 | 100,000 | 101,000 | - | - | Common Shares | |
| Anne Nagengast Johnson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2024 | 100,000 | 100,000 | - | - | Restricted Stock Units | |
| Anne Nagengast Johnson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 550,000 | 550,000 | - | - | Stock Option | |
| Christian Angermayer | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 642,000 | 642,000 | - | - | Stock Option | |
| Sabrina Martucci Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 64,000 | 64,000 | - | - | Stock Option | |
| Amir Kalali | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 64,000 | 64,000 | - | - | Stock Option | |
| Andrea Heslin Smiley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 64,000 | 64,000 | - | - | Stock Option | |
| Michael Auerbach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 64,000 | 64,000 | - | - | Stock Option | |
| Jason Camm | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 64,000 | 64,000 | - | - | Stock Option | |
| Christian Angermayer | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 64,000 | 64,000 | - | - | Stock Option | |
| Florian Brand | See Remarks | Purchase of securities on an exchange or from another person at price $ 1.48 per share. | 29 Mar 2023 | 70,000 | 70,000 | - | 1.5 | 103,558 | Common Shares |
| Srinivas G. Rao | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2023 | 600,000 | 600,000 | - | - | Stock Option | |
| Srinivas G. Rao | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2023 | 350,000 | 350,000 | - | - | Restricted Stock Unit | |
| Florian Brand | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2023 | 700,000 | 700,000 | - | - | Restricted Stock Unit | |
| Florian Brand | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2023 | 1,600,000 | 1,600,000 | - | - | Stock Option | |
| Rolando Gutierrez-Esteinou | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2023 | 500,000 | 500,000 | - | - | Stock Option | |
| Rolando Gutierrez-Esteinou | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2023 | 200,000 | 200,000 | - | - | Restricted Stock Unit | |
| Stephen Bardin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2023 | 350,000 | 350,000 | - | - | Restricted Stock Unit | |
| Stephen Bardin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2023 | 600,000 | 600,000 | - | - | Stock Option | |
| Sahil Kirpekar | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2023 | 275,000 | 275,000 | - | - | Stock Option | |
| Sahil Kirpekar | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2023 | 200,000 | 200,000 | - | - | Restricted Stock Unit | |
| Sahil Kirpekar | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2022 | 750,000 | 750,000 | - | - | Stock Option | |
| Sabrina Martucci Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 64,000 | 64,000 | - | - | Stock Option | |
| Amir Kalali | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 64,000 | 64,000 | - | - | Stock Option | |
| Alexis de Rosnay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 64,000 | 64,000 | - | - | Stock Option | |
| Andrea Heslin Smiley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 64,000 | 64,000 | - | - | Stock Option | |
| Michael Auerbach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 64,000 | 64,000 | - | - | Stock Option | |
| Christian Angermayer | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 64,000 | 64,000 | - | - | Stock Option | |
| Gregory L. Weaver | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 228,000 | 228,000 | - | - | Stock Option | |
| Srinivas G. Rao | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 519,240 | 519,240 | - | - | Stock Option | |
| Srinivas G. Rao | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 840,000 | 840,000 | - | - | Stock Option | |
| Srinivas G. Rao | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 1,307,408 | 1,307,408 | - | - | Stock Option | |
| Florian Brand | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 649,050 | 649,050 | - | - | Stock Option | |
| Rolando Gutierrez-Esteinou | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 206,950 | 206,950 | - | - | Stock Option | |
| Michael Auerbach | Director | Other type of transaction at price $ 0.00 per share. | 14 Jan 2022 | 5,559,808 | 0 | - | 0 | Common Shares | |
| Rolando Gutierrez-Esteinou | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Dec 2021 | 325,000 | 325,000 | - | - | Stock Option | |
| Sabrina Martucci Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2021 | 128,000 | 128,000 | - | - | Stock Option | |
| Amir Kalali | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2021 | 128,000 | 128,000 | - | - | Stock Option | |
| Alexis de Rosnay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2021 | 128,000 | 128,000 | - | - | Stock Option | |
| Andrea Heslin Smiley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2021 | 128,000 | 128,000 | - | - | Stock Option | |
| Michael Auerbach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2021 | 128,000 | 128,000 | - | - | Stock Option | |
| Christian Angermayer | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2021 | 128,000 | 128,000 | - | - | Stock Option | |
| Gregory L. Weaver | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 22 Jun 2021 | 4,666 | 4,666 | - | 15 | 69,990 | Common Shares |
| Amir Kalali | Director | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 22 Jun 2021 | 4,666 | 4,666 | - | 15 | 69,990 | Common Shares |
| Srinivas G. Rao | See Remarks | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 22 Jun 2021 | 3,500 | 3,500 | - | 15 | 52,500 | Common Shares |
| Alexis de Rosnay | Director | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 22 Jun 2021 | 4,666 | 4,666 | - | 15 | 69,990 | Common Shares |
| Alexis de Rosnay | Director | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 22 Jun 2021 | 4,666 | 4,666 | - | 15 | 69,990 | Common Shares |
| Andrea Heslin Smiley | Director | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 22 Jun 2021 | 4,666 | 4,666 | - | 15 | 69,990 | Common Shares |
| Michael Auerbach | Director | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 22 Jun 2021 | 4,666 | 5,564,474 | - | 15 | 69,990 | Common Shares |
| Michael Auerbach | Director | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 22 Jun 2021 | 4,666 | 5,564,474 | - | 15 | 69,990 | Common Shares |
| Florian Brand | See Remarks | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 22 Jun 2021 | 2,333 | 2,333 | - | 15 | 34,995 | Common Shares |
| Christian Angermayer | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 22 Jun 2021 | 700,000 | 20,185,200 | - | 15 | 10,500,000 | Common Shares |
| Gregory L. Weaver | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 67,726 | 67,726 | - | - | Stock Option | |
| Gregory L. Weaver | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 67,726 | 67,726 | - | - | Stock Option | |
| Rolando Gutierrez-Esteinou | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 752,311 | 752,311 | - | - | Stock Option |